M S Stratton

Summary

Affiliation: University of Arizona
Country: USA

Publications

  1. ncbi request reprint Current application of selective COX-2 inhibitors in cancer prevention and treatment
    M Suzanne Stratton
    Arizona Cancer Center, Tucson 85719, USA
    Oncology (Williston Park) 16:37-51. 2002
  2. ncbi request reprint Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study
    M S Stratton
    Arizona Cancer Center, University of Arizona, Tucson, AZ 85716, USA
    Anticancer Drugs 14:589-94. 2003
  3. ncbi request reprint Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' Study
    M S Stratton
    Arizona Cancer Center, University of Arizona, Tucson, AZ 85716, USA
    Anticancer Drugs 14:595-600. 2003
  4. ncbi request reprint A topical lipophilic niacin derivative increases NAD, epidermal differentiation and barrier function in photodamaged skin
    Elaine L Jacobson
    Department of Pharmacology and Toxicology, College of Pharmacy, Tucson, AZ 85724, USA
    Exp Dermatol 16:490-9. 2007
  5. ncbi request reprint Karyometry of nuclei from actinic keratosis and squamous cell cancer of the skin
    James Ranger-Moore
    College of Public Health, Arizona Cancer Center, University of Arizona, Tucson, AZ 85721, USA
    Anal Quant Cytol Histol 25:353-61. 2003
  6. ncbi request reprint Statistical analysis of chemopreventive efficacy of vitamin A in sun-exposed, normal skin
    Peter H Bartels
    Optical Sciences Center, University of Arizona, Tucson, USA
    Anal Quant Cytol Histol 24:185-97. 2002
  7. ncbi request reprint Expression of the matrix metalloproteinase promatrilysin in coculture of prostate carcinoma cell lines
    M S Stratton
    Department of Radiation Oncology, University of Arizona Health Sciences Center, Tucson, AZ 85724, USA
    Prostate 48:206-9. 2001
  8. doi request reprint Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity
    Amit M Algotar
    Arizona Cancer Center, University of Arizona, Tucson, Arizona, USA
    Prostate 70:883-8. 2010
  9. doi request reprint Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer
    M Suzanne Stratton
    Arizona Cancer Center, University of Arizona, Tucson, 85724, USA
    Cancer Prev Res (Phila) 3:1035-43. 2010
  10. ncbi request reprint A report of high-dose selenium supplementation: response and toxicities
    Mary E Reid
    Department of Epidemiology, Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Elm and Carlton Street, Buffalo, NY 14263, USA
    J Trace Elem Med Biol 18:69-74. 2004

Collaborators

Detail Information

Publications13

  1. ncbi request reprint Current application of selective COX-2 inhibitors in cancer prevention and treatment
    M Suzanne Stratton
    Arizona Cancer Center, Tucson 85719, USA
    Oncology (Williston Park) 16:37-51. 2002
    ..These COX-2 data have contributed to initiation of clinical trials testing COX-2 inhibitors for the chemoprevention of a wide variety of cancers that overexpress COX-2...
  2. ncbi request reprint Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study
    M S Stratton
    Arizona Cancer Center, University of Arizona, Tucson, AZ 85716, USA
    Anticancer Drugs 14:589-94. 2003
    ..The goal for accrual is 700 evaluable participants...
  3. ncbi request reprint Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' Study
    M S Stratton
    Arizona Cancer Center, University of Arizona, Tucson, AZ 85716, USA
    Anticancer Drugs 14:595-600. 2003
    ..This report summarizes the primary objectives, research methods and the randomized subjects in this important clinical trial...
  4. ncbi request reprint A topical lipophilic niacin derivative increases NAD, epidermal differentiation and barrier function in photodamaged skin
    Elaine L Jacobson
    Department of Pharmacology and Toxicology, College of Pharmacy, Tucson, AZ 85724, USA
    Exp Dermatol 16:490-9. 2007
    ....
  5. ncbi request reprint Karyometry of nuclei from actinic keratosis and squamous cell cancer of the skin
    James Ranger-Moore
    College of Public Health, Arizona Cancer Center, University of Arizona, Tucson, AZ 85721, USA
    Anal Quant Cytol Histol 25:353-61. 2003
    ....
  6. ncbi request reprint Statistical analysis of chemopreventive efficacy of vitamin A in sun-exposed, normal skin
    Peter H Bartels
    Optical Sciences Center, University of Arizona, Tucson, USA
    Anal Quant Cytol Histol 24:185-97. 2002
    ..To develop numeric, statistically secured measures of chemopreventive efficacy and to derive procedures with high sensitivity of detection...
  7. ncbi request reprint Expression of the matrix metalloproteinase promatrilysin in coculture of prostate carcinoma cell lines
    M S Stratton
    Department of Radiation Oncology, University of Arizona Health Sciences Center, Tucson, AZ 85724, USA
    Prostate 48:206-9. 2001
    ..IL-6, in vivo, may act as a paracrine signaling factor that regulates matrix metalloproteinase expression. Therefore, IL-6 may play a role in invasive metastatic processes of a prostate carcinoma...
  8. doi request reprint Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity
    Amit M Algotar
    Arizona Cancer Center, University of Arizona, Tucson, Arizona, USA
    Prostate 70:883-8. 2010
    ..Aspirin, other non-steroidal anti-inflammatory drugs (NSAIDs), and statins have been associated with lower risk of prostate cancer and its progression, though results have been inconsistent...
  9. doi request reprint Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer
    M Suzanne Stratton
    Arizona Cancer Center, University of Arizona, Tucson, 85724, USA
    Cancer Prev Res (Phila) 3:1035-43. 2010
    ..On the contrary, supplementation with high-dose selenium was observed to be a risk factor for increased PSA velocity in men with high baseline plasma selenium concentrations...
  10. ncbi request reprint A report of high-dose selenium supplementation: response and toxicities
    Mary E Reid
    Department of Epidemiology, Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Elm and Carlton Street, Buffalo, NY 14263, USA
    J Trace Elem Med Biol 18:69-74. 2004
    ..As selenium is used in more chemoprevention and therapeutic settings, additional information on selenium species, sequestration of selenium in specific organs, excretion, and toxicities is needed...
  11. ncbi request reprint Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial
    Anna J Duffield-Lillico
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Natl Cancer Inst 95:1477-81. 2003
    ....
  12. ncbi request reprint Prostate cancer screening: a racial dichotomy
    Isis Calsoyas
    Arch Intern Med 164:1830-2. 2004
  13. ncbi request reprint Androgens block interleukin-1 beta-induced promatrilysin expression in prostate carcinoma cells
    M Suzanne Stratton
    Department of Radiation Oncology, Arizona Cancer Center, Tucson, Arizona 85724, USA
    Prostate 53:1-8. 2002
    ..We now demonstrate that IL-1 beta-induced but not IL-6-induced promatrilysin expression can be blocked by androgens in the prostate carcinoma cell line LNCaP (lymph node-derived carcinoma cells of the prostate)...